Glenview Capital Management, founded in 2000 by Larry Robbins (Trades, Portfolio), is a privately held investment management firm. During the fourth quarter, he bought shares in many stocks, including the following.Â
Robbins increased his stake in HCA Holdings Inc. (HCA) by 159.38%, and the deal had an impact of 3.35% on the portfolio.
It is a health care services company in the U.S. It operates 166 hospitals, comprised of 162 general, acute care hospitals; three psychiatric hospitals; and one rehabilitation hospital. Fourth quarter revenues grew 6.4% and adjusted EBITDA increased 8.9% year over year.
GuruFocus gives the stock a profitability and growth rating of 9 out of 10 with ROA of 6.71% that is outperforming 61% of the companies in the Global Medical Care industry.
Other notable shareholders among the gurus are Vanguard Health Care Fund (Trades, Portfolio) with 3% of outstanding shares, David Tepper (Trades, Portfolio) with 1.14%, Richard Perry (Trades, Portfolio) with 0.77%, Jim Simons (Trades, Portfolio) with 0.07% and Joel Greenblatt (Trades, Portfolio) with 0.06%.
Robbins raised his stake in Cigna Corp. (CI) by 52.21% and the deal had an impact of 1.98% on the portfolio.
It is a health services organization with insurance subsidiaries that are providers of medical, dental, disability, life and accident insurance and related products and services. In the U.S., the majority of these products and services are offered through employers and other groups and in selected international markets. During the last quarter, consolidated revenues increased 8% and adjusted income from operations for 2015 was $8.66 per share, with per share growth of 10% over 2014.
GuruFocus gives the stock a profitability and growth rating of 7 out of 10 with ROE of 18.43% and ROA of 3.67% that are underperforming 56% of companies in the Global Health Care Plans industry. Financial strength has a rating of 6 out of 10, with cash to debt of 0.38 that is below the industry median of 1.57.
The largest shareholders among the gurus are Dodge & Cox with 5.28% of outstanding shares, followed by Vanguard Health Care Fund (Trades, Portfolio) with 2.78%, Barrow, Hanley, Mewhinney & Strauss with 0.97%, Richard Pzena (Trades, Portfolio) with 0.5%, Eric Mindich (Trades, Portfolio) with 0.37% and Jeremy Grantham (Trades, Portfolio) with 0.22%.
The investor increased its stake in Humana Inc. (HUM) by 24.35% and the deal had an impact of 1.62% on the portfolio.
The company is a health care company that offers insurance products and health and wellness services. Its segments include Retail, Employer Group and Healthcare Services.
GuruFocus gives the stock a profitability and growth rating of 6 out of 10 with ROE of 12.64% and ROA of 5.17% that are outperforming 62% of the companies in the Global Health Care Plans industry. Financial strength has a rating of 6 out of 10, with a cash-to-debt of 0.58 that is below the industry median of 1.57.
Andreas Halvorsen (Trades, Portfolio) is another notable shareholder of the company among the gurus with 2.92% of outstanding shares, followed by Jeremy Grantham (Trades, Portfolio) with 0.76%, HOTCHKIS & WILEY with 0.67%, Eric Mindich (Trades, Portfolio) with 0.25% and David Einhorn (Trades, Portfolio) with 0.24%.
The guru acquired 6,879,290 shares in Computer Sciences Corp. (CSC) with an impact of 1.27% on the portfolio.
The company provides information technology and professional services and solutions. The company has helped its clients develop and integrate their IT assets in support of operational efficiency, new growth initiatives and other business objectives.
GuruFocus gives the stock a profitability and growth rating of 4 out of 10 with ROE of 13.09% and ROA of 3.87% that are outperforming 54% of the companies in the Global Information Technology Services industry. Financial strength has a rating of 6 out of 10, with cash to debt of 0.69 that is far below industry median of 13.08.
Another notable shareholder among the gurus is Jana Partners (Trades, Portfolio) with 3.45% of outstanding shares, followed by Joel Greenblatt (Trades, Portfolio) with 1.2%, Paul Tudor Jones (Trades, Portfolio) with 0.74%, Jim Simons (Trades, Portfolio) with 0.11% and Dodge & Cox with 0.04%.
Robbins increased his stake in FMC Corp. (FMC) by 78.19% and the deal had an impact of 1.15% on the portfolio.
It is a chemical company serving agricultural, consumer and industrial markets globally with original solutions, applications and products. During the fourth quarter, adjusted earnings from continuing operations had a decline of 22% compared to the prior year and revenue had a 1% increase.
GuruFocus gives the stock a profitability and growth rating of 6 out of 10 with ROE of 26.72% and ROA of 8.02% that are outperforming 75% of the companies in the Global Chemicals industry. Financial strength has a rating of 6 out of 10, with a cash-to-debt of 0.04 that is far below the industry median of 0.71.
Barrow, Hanley, Mewhinney & Strauss is another notable shareholder of the company among the gurus with 4.72% of outstanding shares, followed by Meridian Funds (Trades, Portfolio) with 0.62%, Westport Asset Management (Trades, Portfolio) with 0.28%, Richard Snow (Trades, Portfolio) with 0.15% and Jim Simons (Trades, Portfolio) with 0.11%.
Robbins raised his stake in Teva Pharmaceutical Industries Ltd. (TEVA) by 42.18% and the deal had an impact of 0.65% on the portfolio.
The company manufactures generic pharmaceutical products. It operates in two segments such as generic products, which includes chemical and therapeutic equivalents of originator pharmaceuticals in a variety of dosage forms. Last year non-GAAP gross profit was up 1% compared to 2014 and non-GAAP operating income was up 6%.
GuruFocus gives the stock a profitability and growth rating of 7 out of 10 with ROE of 6.47% and ROA of 3.22% that are underperforming 52% of the companies in the industry. Financial strength has a rating of 6 out of 10, with cash to debt of 0.70 that is far below the industry median of 2.90.
The largest shareholder among the gurus is Andreas Halvorsen (Trades, Portfolio) with 2.76% of outstanding shares, followed by John Paulson (Trades, Portfolio) with 2.25%, Barrow, Hanley, Mewhinney & Strauss with 1.06%, Vanguard Health Care Fund (Trades, Portfolio) with 0.64%, First Eagle Investment (Trades, Portfolio) with 0.48% and John Griffin (Trades, Portfolio) with 0.44%.
Robbins increased his stake in Dow Chemical Co. (DOW) by 27.61% and the deal had an impact of 0.58% on the portfolio.
The company is as an integrated science and technology company. It operates in five segments: Agricultural Sciences, Consumer Solutions, Infrastructure Solutions, Performance Materials & Chemicals and Performance Plastics.
GuruFocus gives the stock a profitability and growth rating of 5 out of 10 with ROE of 31.13% and ROA of 11.18% that are outperforming 85% of the companies in the Global Chemicals industry. Financial strength has a rating of 7 out of 10, with a cash-to-debt of 0.50 that is below the industry median of 0.71.
Daniel Loeb (Trades, Portfolio) is the largest shareholder of the company among the gurus with 2.26% of outstanding shares, followed by George Soros (Trades, Portfolio) with 0.28%, Leon Cooperman (Trades, Portfolio) with 0.24%, Pioneer Investments (Trades, Portfolio) with 0.21% and PRIMECAP Management (Trades, Portfolio) with 0.14%.
The guru raised his stake in Aramark (ARMK) by 113.19% and the deal had an impact of 0.52% on the portfolio.
It is a provider of food, facilities and uniform services to education, healthcare, business and industry, and sports, leisure and corrections clients.
GuruFocus gives the stock a profitability and growth rating of 5 out of 10 with ROE of 13.13% and ROA of 2.38%. Financial strength has a rating of 5 out of 10, with cash to debt of 0.02 that is far below the industry median of 0.62.
The largest shareholder among the gurus is Lee Ainslie (Trades, Portfolio) with 5.09% of outstanding shares, followed by Joel Greenblatt (Trades, Portfolio) with 0.46%, Jim Simons (Trades, Portfolio) with 0.37%, RS Investment Management (Trades, Portfolio) with 0.33%, Louis Moore Bacon (Trades, Portfolio) with 0.33% and Steven Cohen (Trades, Portfolio) with 0.07%.
Also check out:
